Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2022

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	March 31, 2022		December 31, 2021
Current assets	$	214,229	$	246,342
Noncurrent assets		2,338		2,180
Total assets		216,567		248,522
Current liabilities		150,474		175,637
Total liabilities		150,474		175,637
Total joint venture equity	$	66,093	$	72,885

	Three Months Ended
	March 31, 2022		March 31, 2021
Revenue	$	95,534	$	96,624
Costs		88,842		86,306
Net income	$	6,692	$	10,318
Net income attributable to noncontrolling interests	$	3,176	$	4,975

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	March 31, 2022		December 31, 2021
Current assets	$	1,707,836	$	1,620,735
Noncurrent assets		539,798		531,261
Total assets		2,247,634		2,151,996
Current liabilities		1,252,393		1,088,985
Noncurrent liabilities		603,929		669,911
Total liabilities		1,856,322		1,758,896
Total joint venture equity	$	391,312	$	393,100
Investments in and advances to unconsolidated joint ventures	$	114,234	$	110,688

	Three Months Ended
	March 31, 2022		March 31, 2021
Revenue	$	384,581	$	236,517
Costs		373,286		210,847
Net income	$	11,295	$	25,670
Equity in earnings of unconsolidated joint ventures	$	5,598	$	7,530